(Q37400842)

20 August 2017

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes (English)

1 reference

20 August 2017

0 references

1 reference

Markus Walter

1

1 reference

20 August 2017

Areti Philotheou

2

1 reference

20 August 2017

François Bonnici

3

1 reference

20 August 2017

Anette-G Ziegler

4

1 reference

20 August 2017

Roland Jimenez

5

1 reference

20 August 2017

NBI-6024 Study Group

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

18 August 2009

1 reference

20 August 2017

1 reference

20 August 2017

32

1 reference

20 August 2017

2036-2040

1 reference

20 August 2017

11

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

20 August 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Analysis of the spontaneous T cell response to insulin in NOD mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Type I diabetes mellitus. A chronic autoimmune disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768201

Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19690081

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

NBI-6024 (Neurocrine Biosciences)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19690081

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC09-0449

1 reference

20 August 2017

1 reference

20 August 2017

1 reference